#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Philadelphia chromosome positive Nodal marginal zone B-cell lymphoma Hidradenitis Myxoid liposarcoma Blood iron increased Propionic acidaemia Gestational trophoblastic tumour Kidney transplant rejection Burkitt's lymphoma refractory Pancreatic neuroendocrine tumour Mantle cell lymphoma recurrent Leukocyte adhesion deficiency Anal cancer recurrent Osteosarcoma recurrent Netherton's syndrome More trials…

    Learn about Rare Diseases

    Cholangitis sclerosing – Diagnostics Chronic granulomatous disease Ornithine transcarbamoylase deficiency – Life with Disease Mantle cell lymphoma refractory – Trials in Disease Haemophilia A with anti factor VIII – Treatment Retinitis pigmentosa – Life with Disease Adrenocortical carcinoma Rosai-Dorfman syndrome – Basic Information Niemann-Pick disease – Basic Information Haemophilia B with anti factor IX – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Keto-Isoleucine Calcium S-241656 ABBV-CLS-628 Enmetazobactam Burfiralimab 11902A Pegenzileukin Paclitaxel Albumin-Bound Clofazimine Tecovirimat Diltiazem Hydrochloride VMX-C001 Lamotrigine Adct-402 Benzylpenicillin Sodium Hhalpc Pegunigalsidase Alfa Celecoxib Florquinitau (18F) Folinic Acid More therapies…

    Learn about Your Condition

    Skin angiosarcoma Eclampsia Gender dysphoria B-cell type acute leukaemia Emphysema Pseudomonas infection Vascular malformation Spinal cord injury cervical Prolymphocytic leukaemia Hairy cell leukaemia recurrent Retinal vein occlusion Cholangiocarcinoma Medication overuse headache Aplastic anaemia Renal cell carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Circulatory and Respiratory Physiological Phenomena

  • Evaluating Morphine Effectiveness Based on Kidney Function in Patients with Sickle Cell Disease During Vaso-occlusive Crisis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Sickle cell anaemia
    Investigated Drugs:
    • Iohexol
    • Morphine Hydrochloride
    France
  • Study on the Effects of Potassium Canrenoate and Trometamol on Blood Flow in Brain-Dead Organ Donors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Organ donor
    Investigated Drugs:
    • Potassium Canrenoate
    • Trometamol
    • Sodium Chloride
    France
  • Study on the Safety of Ticagrelor and Aspirin in Patients with ST-Elevation Myocardial Infarction After Heart Procedure

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Acetylsalicylic Acid
    The Netherlands
  • Study on Sildenafil for Adults with Single Ventricle Heart Condition Post-Fontan Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Univentricular heart
    • Fontan procedure
    Investigated Drugs:
    • Sildenafil
    Poland
  • Study on the Effects of Belatacept, Ciclosporin, and Tacrolimus on Blood Vessel Health in Kidney Transplant Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Glyceryl Trinitrate
    • Belatacept
    • Ciclosporin
    France
  • Study of EXL-01 and Nivolumab for Patients with Advanced Non-Small Cell Lung Cancer Resistant to Immunotherapy

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Exl01
    • Nivolumab
    France
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!